Clinical Trials Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Aug 6, 2021; 9(22): 6308-6318
Published online Aug 6, 2021. doi: 10.12998/wjcc.v9.i22.6308
Table 6 Comparison of matrix metalloproteinase-9, tissue inhibitor of metalloproteinases-1, and matrix metalloproteinase-9/tissue inhibitor of metalloproteinases-1 ratio in rehabilitation exercise and control groups at different time points
Items
Time
Rehabilitation exercise group (n = 30)
Control group (n = 30)
MMP-9 (ng/mL)Immediately 6.7 ± 2.976.8 ± 3.12
Days 10-14 8.2 ± 2.58.1 ± 2.55
Day 30 4.2 ± 1.885.0 ± 1.98a
6 mo4.0 ± 1.875.1 ± 2.02a
TIMP-1 (ng/mL)Immediately 2.1 ± 0.522.1 ± 0.51
Days 10-14 2.4 ± 0.712.5 ± 0.65
Day 30 2.8 ± 0.673.0 ± 0.55a
6 mo2.7 ± 0.562.98 ± 0.51a
MMP-9/TIMP-1Immediately 3.05 ± 1.052.98 ± 1.03
Days 10-14 4.21 ± 1.584.11 ± 1.44
Day 30 1.78 ± 0.881.25 ± 0.66a
6 mo1.58 ± 0.671.22 ± 0.58a